Fellowship

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

Search
Generic filters
Search
Generic filters

Name

Position

Level

Elected

State

Professor
The Doherty Institute
Fellow
2017
VIC

Dale Godfrey is a Professor in the Department of Microbiology and Immunology at The Peter Doherty Institute, University of Melbourne. He is an NHMRC Senior Principal Research Fellow and Immediate Past President of the Australasian Society for Immunology. Over the past 25 years, working in the field of Immunology, Godfrey has defined and studied new types of white blood cells, deciphering their developmental and functional characteristics and therapeutic potential. Godfrey’s work has had a major impact, internationally, as clearly demonstrated by his outstanding publication record with many highly cited papers in top-tier journals.

 

 

Professor of Anatomy and Neuroscience
University of Melbourne
Fellow
2017
VIC

Professor Furness is a leading authority on digestive physiology, especially the neural control of the digestive tract. He has been strongly involved in evaluation of therapeutic drugs and has run clinical trials of candidate drugs. He is currently the leader of a program to develop vagal nerve stimulation for the treatment of inflammatory bowel disease. This is projected for first in human trials in 2018.  He is one of Australia’s most highly cited scientists. He is best known for his work in analysing enteric nerve circuits and for developing the concept of neural chemical coding.

Executive Director, Monash Partners Academic Health Sciences Centre, Director, Monash Centre For Health Research And Implementation
Monash University
Fellow
2017
VIC

Professor Teede is a clinician, academic, and leader committed to research and translation, delivering measurable changes in policy and practice. She is nationally and internationally recognised for excellence in health and medical research, exceptional leadership, and community engagement. Focusing on improving women’s reproductive health, she has spearheaded the development of the first evidence-based guidelines on PCOS in the world, pioneered interventions for preventing obesity in women, and established one of only four national Diabetes Centres of Excellence. Having raised a family and maintained an active academic and clinical career, she is a role model for women in her profession.

 

 

Director, Institute of Vector-Borne Disease / Director, Impact Assessment, World Mosquito Program
Monash University
Fellow
2017
VIC

Professor Cameron Simmons is an internationally recognised infectious disease scientist who has made an outstanding contribution to the understanding of dengue. He has been at the forefront of developing and testing novel approaches to improve individual patient outcomes through better diagnosis, prognosis and testing of new treatment options. As Director of Impact Assessment in the Eliminate Dengue Program, he is leading clinical and epidemiological research into Wolbachia for the biocontrol of dengue and Zika. His expertise in the field is recognised through appointments to technical committees at WHO, invitations to international meetings and advisory roles to academic and private sector entities.

 

Director, Department of Molecular Imaging and Therapy; Head, Tumour Targeting Laboratory
Austin Health, ONJCRI
Fellow
2017
VIC

Professor Andrew Scott has made significant contributions to science and medicine through the discovery of novel therapeutic antibodies that are impacting on cancer patient outcomes, and the development of evidence for positron emission tomography (PET) that has led to the approval of multiple Medicare clinical indications for accurately staging cancer patients. He has provided leadership of scientific and medical professional organisations and in public education. Professor Scott is recognised Internationally for his research and clinical expertise, and for advocacy of molecular imaging and therapy, reflected by his recent election as President of the World Federation of Nuclear Medicine and Biology.

 

AO FASSA FAHMS
Director, Southgate Institute of Health, Society & Equity
Flinders University
Fellow
2017
SA

Baum is an international leader in public health social science. She has made major contributions to the understanding of the social determinants of health, health promotion and to the use of qualitative methods. She has published 179 refereed articles, 10 books, 40 book chapters, 68 reports for government or international agencies, and given 185 keynote or invited addresses. Her work is widely cited with 6056 citations (GS) and an H-index of 38 (GS). She is a Fellow of the Academy of Social Sciences in Australia and a Life Member of the Public Health Association.

Dean
College of Science
Australian National University
Fellow
2017
ACT

Professor Kiaran Kirk is Dean of the Australian National University’s College of Science. His primary research interest is in the biology of the malaria parasite with a particular focus on the mechanism of action of, and mechanisms of resistance to, antimalarial drugs. His work has had significant translational impact, with the biochemical assays that he and his colleagues have developed now being used to assess the mechanism of action of drugs entering the antimalarial drug-development pipeline, to ensure that that there is not overinvestment in compounds sharing the same molecular target

 

Professor of Hepatic Medicine
ANU Medical School at The Canberra Hospital
Fellow
2016
ACT

Geoff Farrell is an international authority on fatty liver associated with overweight and diabetes, and how its serious form, NASH, develops and leads to cirrhosis and liver cancer. His discovery that cholesterol damages liver cells to provoke inflammation is fundamental to devising effective NASH treatments. Farrell led Asian-Pacific guidelines on prevention and management of NASH, a world first, and on prevention of liver cancer. He has been lead investigator of NIH and NHMRC program and project grants, supervised 26 PhD candidates (6 now run their own labs), and published 4 books, more than 220 scientific articles and 140 reviews, editorials and chapters.

Director of Pathology
Peter MacCallum Cancer Centre
Fellow
2016
VIC

Stephen Fox is an internationally recognised anatomical and molecular pathologist. He is known for his research in the field of tumour blood vessel formation where he elucidated the mechanism by which a tumour establishes a blood supply that is critical to its growth and spread. He has shown the importance of these in breast tumours and its effect on patient response to treatment. He has developed and implemented novel molecular cancer testing from research to diagnostic laboratories and written several Australian guidelines that has changed the way laboratories test for genetic changes in cancer.

Foundation Chair of Dementia Research, Director, Clem Jones Centre for Ageing Dementia Research
Queensland Brain Institute, The University of Queensland
Fellow
2016
QLD

Alzheimer’s Disease is characterized by amyloid plaques and tau tangles. Understanding their role in pathology is crucial for developing a treatment for this yet incurable disease.  Professor Jürgen Götz generated the first transgenic mouse model with a tau pathology.  By combining a transgenic with a transplantation approach he proved the amyloid cascade hypothesis, a concept central in the field, and showed that amyloid induces a tau pathology.  He also demonstrated that tau is needed for amyloid to exert toxicity, by ‘axonal’ tau assuming a previously unidentified function in dendrites.  He developed a novel scanning ultrasound approach to reduce amyloid toxicity.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants. 

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community
      •  

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the Secretariat for application forms and further instructions on how to submit the completed nomination documentation. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the Secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2021
Newly elected Fellows of 2021 are inducted at the AGM/Scientific Meeting.

October 2021-November 2021
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2021
Nominations allocated to Selection Committees.

January – April 2022
Referees’ reports sought.

Early May 2022
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-Mid-July 2022
Council meets to finalise recommendations.

Late July 2022
Full Fellowship invited to comment on recommended new fellows.

Early August 2022
Newly elected Fellows are informed of their successful appointment.

October 2022
Newly elected Fellows of 2022 inducted at the AGM/Scientific Meeting.

Find out more

Whether you’re looking to nominate a colleague for an award, make a donation to the Academy or simply find out more about the work we do, research we advance and health policy advice we provide, sign up to our mailing list today.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.